Australia to reduce regulatory burden for drugs and devices
This article was originally published in Scrip
Executive Summary
Three experts are to conduct an independent assessment of Australia's Therapeutic Goods Administration with a view to streamlining the agency's regulatory processes for medicines and medical devices, improving access to medicines, and boosting productivity and competitiveness.